Liquid Biopsies in Esophageal Cancer

Recruiting now · Not applicable

Conditions studied: Esophageal Cancer

In brief

Purpose of this study is to determine the value of liquid biopsies, e.g. testing of minimal residual disease (MRD) by using liquid biopsies to measure circulating tumour DNA (ctDNA) at diagnosis and during the multimodal and multidisciplinary curative-intent treatment of resectable esophageal cancer.

Key facts

Study ID

NCT05704530

Run by

Universitaire Ziekenhuizen KU Leuven

People needed

248

Starts

2023-03-29

Expected to finish

2029-12-31

Last updated by the study team

2026-06-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UZA — Antwerp, Belgium (enrolling)
• UZ Gent — Ghent, Belgium (enrolling)
• UZLeuven — Leuven, Belgium (enrolling)
• AZ Delta — Roeselare, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.